Spine

Premia Spine confirms $7M raise for spinal fusion alternative

May 30, 2014 by Arezu Sarvestani

Premia Spine CEO Ron Sacher confirms reports that the company has raised $7 million in a $10 million funding round in support of wider clinical trials for the company’s spinal plates.

Israeli device maker Premia Spine confirmed today that it had raised $7 million, planning on using part of the funds to pursue FDA approval for its spinal fixation devices.

CEO Ron Sacher told MassDevice.com today that the reports about the company’s latest fundraising efforts are true, and that Premia is looking to raise another $3 million to close out the financing round.

READ THE REST AT MASSDEVICE

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button